Replies to post #27166 on Cel Sci Corporation (CVM)

[Fosco1]

"Should I be using the logarithmic values from the 1st tab or 2nd tab on your spreadsheet?"


Tab 2 is the survival for the exact inclusion criteria of this trial

But your question is what survival curve will be right for this CT.

That's the 12 B question.

We don't know how the patients will react in the clinical trial. Their survival should be better in this CT than from their national benchmarks because of better care and follow up than than most of the countries patients. Now the SEER data is from the US only, national should be really bad, SEER better, clinical trial better or same than SEER ? ??? How much better ???? Time will tell